Status:
COMPLETED
Inflammatory Biomarkers to Diagnose and Monitor Diabetic Foot Osteomyelitis
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Diabetic Foot Ulcer
Eligibility:
All Genders
18-89 years
Brief Summary
The investigators plan to do a retrospective chart review of 500 patients admitted to the hospital between January 1, 2010 and December 31, 2015 with diabetic foot infections. The investigators will d...
Detailed Description
Introduction and Purpose: Foot infections are one of the most common reasons for hospitalization and amputation in persons with diabetes. It is often difficult to determine if diabetic foot ulcers ha...
Eligibility Criteria
Inclusion
- Patients of the investigators.
- Male and female
- ages 18-89
- moderate diabetic foot infections (according to IDSA criteria) and non-diabetic foot infections who presented for treatment between January 1, 2010 and December 31, 2015. •positive case of osteomyelitis as bone with positive bacterial cultures or histologic finding of acute or chronic osteomyelitis.
- The investigators will only enroll patients who have an initial baseline CRP or ESR within 72 hours of admission, before any surgical procedures.
Exclusion
- •Not meeting inclusion criteria.
Key Trial Info
Start Date :
June 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2018
Estimated Enrollment :
455 Patients enrolled
Trial Details
Trial ID
NCT04025853
Start Date
June 1 2015
End Date
March 1 2018
Last Update
July 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT Southwestern Medical Center at Dallas
Dallas, Texas, United States, 75390